✦ LIBER ✦

Response to toremifene (Fc-1157a) therapy in tamoxifen failed patients with breast cancer. Preliminary communication

✍ Scribed by S.R. Ebbs; J. Roberts; M. Baum

Book ID: 116007771
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 85 KB
Volume: 36
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(90)90016-l

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Responses to Tamoxifen withdrawal and se

Responses to Tamoxifen withdrawal and second line endocrine therapy — Clinical clues to the mechanisms of Tamoxifen failure in patients with advanced breast cancer

✍ DeFriend, DJ; Dodwell, DJ; Anderson, H; Howell, A 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 163 KB

The expression of Ki-S1 and BCL-2 and th

The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer

✍ J.C. Keen; J.M. Dixon; E.P. Miller; D.A. Cameron; U. Chetty; A. Hanby; C. Bellam 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 620 KB

Adjuvant therapy with GnRH agonists/tamo

Adjuvant therapy with GnRH agonists/tamoxifen in breast cancer should be a good council for patients with hormone receptor-positive tumours and wish to preserve fertility

✍ J.G. Franco Jr; J.B.A. Oliveira; C.G. Petersen; A.L. Mauri; R. Baruffi; M. Cavag 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Clinical response to primary letrozole t

Clinical response to primary letrozole therapy in elderly patients with early breast cancer: Possible role for p53 as a biomarker

✍ Garimella, Veerabhadram; Hussain, Tasadooq; Agarwal, Vijay; Radhakrishna, Selvi; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Hypoxia inducible factor-1α is a prognos

Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response

✍ Åsa Kronblad; Karin Jirström; Lisa Rydén; Bo Nordenskjöld; Göran Landberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 765 KB

## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting

Urinary N-Telopeptide Is a Rapid Predict

Urinary N-Telopeptide Is a Rapid Predictor of Response to and Palliative Benefit from Bisphosphonate Therapy in Patients with Metastatic Breast Cancer

✍ Simmons, Christine; Broom, Reuben J.; Cole, David E.C.; Dranitsaris, George; Cle 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 418 KB